Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
10.92
-0.23 (-2.06%)
Jul 30, 2025, 4:00 PM - Market closed
Despegar.com Revenue
Coeptis Therapeutics Holdings had revenue of $62.87K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $62.87K.
Revenue (ttm)
$62.87K
Revenue Growth
n/a
P/S Ratio
610.29
Revenue / Employee
$8,982
Employees
7
Market Cap
38.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 75.00K | 44.24K | 143.82% |
| Dec 31, 2020 | 30.76K | 6.67K | 27.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 57.37B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
COEP News
- 9 days ago - Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd - GlobeNewsWire
- 5 weeks ago - Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared - GlobeNewsWire
- 2 months ago - Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology - GlobeNewsWire
- 3 months ago - Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement - GlobeNewsWire
- 3 months ago - COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology - GlobeNewsWire
- 5 months ago - Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline - GlobeNewsWire
- 5 months ago - COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan - GlobeNewsWire
- 5 months ago - NUBURU Partners With COEPTIS NexGenAI Affiliates Network to Drive Innovation in AI and Robotics as Part of Its Transformation Plan - Business Wire